JPMorgan Starts PTC Therapeutics (PTCT) at Overweight
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $25.41 -2.16%
Rating Summary:
8 Buy, 9 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
8 Buy, 9 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
JPMorgan initiates coverage on PTC Therapeutics (NASDAQ: PTCT) with a Overweight. PT $20.00.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $16.94 yesterday.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $16.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Starts Auna SA (AUNA) at Buy, 'Just what the doctor prescribed'
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- Cantor Fitzgerald Starts Incyte (INCY) at Neutral, 'JAK-ing Up Its Pipeline In Advance of a Major Patent Cliff'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
